JIUN-KAE JACK LEE to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications JIUN-KAE JACK LEE has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.087
-
Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Cancer Res. 2006 Mar 15; 66(6):2893-903.
Score: 0.056
-
Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease. Mol Cancer Ther. 2013 Jun; 12(6):1112-21.
Score: 0.023
-
Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst. 1998 Feb 04; 90(3):243-5.
Score: 0.008